239 related articles for article (PubMed ID: 18027228)
21. The advantages and disadvantages of adaptive designs for clinical trials.
Bauer P; Brannath W
Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
[TBL] [Abstract][Full Text] [Related]
22. Inference for clinical trials with some protocol amendments.
Chow SC; Shao J
J Biopharm Stat; 2005; 15(4):659-66. PubMed ID: 16022170
[TBL] [Abstract][Full Text] [Related]
23. Issues in designing flexible trials.
Posch M; Bauer P; Brannath W
Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
[TBL] [Abstract][Full Text] [Related]
24. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
Schäfer H; Müller HH
Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
[TBL] [Abstract][Full Text] [Related]
25. Sample size re-estimation for survival data in clinical trials with an adaptive design.
Togo K; Iwasaki M
Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
[TBL] [Abstract][Full Text] [Related]
26. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
Bénichou J; Lepage E; Chastang C
Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
[TBL] [Abstract][Full Text] [Related]
27. Stopping boundaries adjusted for sample size reestimation and negative stop.
Shun Z
J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
[TBL] [Abstract][Full Text] [Related]
28. Flexible two-stage design with sample size reassessment for survival trials.
Desseaux K; Porcher R
Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
[TBL] [Abstract][Full Text] [Related]
29. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
Cheng Y; Shen Y
Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
[TBL] [Abstract][Full Text] [Related]
30. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
31. An adaptive approach to implementing bivariate group sequential clinical trial designs.
Todd S
J Biopharm Stat; 2003 Nov; 13(4):605-19. PubMed ID: 14584711
[TBL] [Abstract][Full Text] [Related]
32. Adaptive Dunnett tests for treatment selection.
Koenig F; Brannath W; Bretz F; Posch M
Stat Med; 2008 May; 27(10):1612-25. PubMed ID: 17876763
[TBL] [Abstract][Full Text] [Related]
33. Standard versus adaptive monitoring procedures: A commentary.
Fleming TR
Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
[TBL] [Abstract][Full Text] [Related]
34. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
35. A note on P-values under group sequential testing and nonproportional hazards.
Gillen DL; Emerson SS
Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
[TBL] [Abstract][Full Text] [Related]
36. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
37. Adaptive trial design: a general methodology for censored time to event data.
Jahn-Eimermacher A; Ingel K
Contemp Clin Trials; 2009 Mar; 30(2):171-7. PubMed ID: 19130902
[TBL] [Abstract][Full Text] [Related]
38. Adjusted significance levels for subgroup analyses in clinical trials.
Spiessens B; Debois M
Contemp Clin Trials; 2010 Nov; 31(6):647-56. PubMed ID: 20832503
[TBL] [Abstract][Full Text] [Related]
39. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
40. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
Srivastava DK; Rai SN; Pan J
Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
